Portside Wealth Group LLC Buys 283 Shares of Relx Plc (NYSE:RELX)

Portside Wealth Group LLC lifted its position in Relx Plc (NYSE:RELXFree Report) by 2.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,710 shares of the technology company’s stock after buying an additional 283 shares during the quarter. Portside Wealth Group LLC’s holdings in Relx were worth $590,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in RELX. Merit Financial Group LLC grew its holdings in Relx by 77.7% during the first quarter. Merit Financial Group LLC now owns 11,757 shares of the technology company’s stock worth $593,000 after purchasing an additional 5,139 shares during the period. Rhumbline Advisers lifted its position in shares of Relx by 1.2% in the first quarter. Rhumbline Advisers now owns 34,906 shares of the technology company’s stock valued at $1,760,000 after buying an additional 411 shares during the last quarter. Parallel Advisors LLC boosted its stake in shares of Relx by 37.3% during the 1st quarter. Parallel Advisors LLC now owns 8,093 shares of the technology company’s stock worth $408,000 after acquiring an additional 2,197 shares during the period. Summit Global Investments acquired a new position in shares of Relx during the 1st quarter worth approximately $1,130,000. Finally, GAMMA Investing LLC raised its stake in Relx by 6,125.5% in the 1st quarter. GAMMA Investing LLC now owns 679,073 shares of the technology company’s stock valued at $34,232,000 after acquiring an additional 668,165 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Relx Stock Performance

Shares of NYSE:RELX opened at $54.37 on Thursday. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33. The company’s 50 day moving average price is $52.53 and its two-hundred day moving average price is $49.60. The firm has a market cap of $100.36 billion, a PE ratio of 29.23, a PEG ratio of 2.73 and a beta of 0.86. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46.

Wall Street Analyst Weigh In

RELX has been the subject of several research reports. The Goldman Sachs Group assumed coverage on Relx in a report on Wednesday, March 26th. They set a “buy” rating for the company. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a research note on Friday, March 14th. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. Finally, Wall Street Zen downgraded shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy”.

Get Our Latest Report on RELX

Relx Profile

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Read More

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELXFree Report).

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.